[1]
R. Fatima, M. A. Siddiqui, and H. Ejaz, “Comparison between Tab Tofacitinib and Low-Dose Oral Steroid in Patients Having Vitiligo Over 6 Months”, JHRR, vol. 4, no. 1, pp. 917–921, Feb. 2024.